< Back to previous page

Publication

SECUKINUMAB PROVIDES SUSTAINED IMPROVEMENTS IN THE SIGNS AND SYMPTOMS IN PSORIATIC ARTHRITIS: FINAL 5-YEAR EFFICACY AND SAFETY RESULTS FROM THE FUTURE 1 PHASE 3 TRIAL

Journal Contribution - Journal Abstract Conference Contribution

Journal: RHEUMATOLOGY
ISSN: 1462-0324
Issue: S3
Volume: 58
Pages: 151 - 151
Publication year:2019
Accessibility:Closed